StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.11+0.10 (+0.30%)

Close on Nov 18, 2026Market cap $1.93BP/E 10.7Yield –

Harmony Biosciences total assets

Total assets on the balance sheet at the end of each period.

Harmony Biosciences's total assets was $1.37B at Jun 30, 2026. For fiscal 2025 it was $1.27B, up 27.3% from the year before. The highest annual figure on record is $1.27B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.27B+27.3%
FY2024Dec 31, 2024$999.20M+23.1%
FY2023Dec 31, 2023$811.45M+20.4%
FY2022Dec 31, 2022$673.87M+55.5%
FY2021Dec 31, 2021$433.44M+1.5%
FY2020Dec 31, 2020$427.07M+300.2%
FY2019Dec 31, 2019$106.70M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.37B+23.9%
Q1 FY2026Mar 31, 2026$1.27B+20.5%
Q4 FY2025Dec 31, 2025$1.27B+27.3%
Q3 FY2025Sep 30, 2025$1.21B+30.2%
Q2 FY2025Jun 30, 2025$1.11B+29.1%
Q1 FY2025Mar 31, 2025$1.06B+24.6%
Q4 FY2024Dec 31, 2024$999.20M+23.1%
Q3 FY2024Sep 30, 2024$928.14M+19.3%
Q2 FY2024Jun 30, 2024$858.38M+12.9%
Q1 FY2024Mar 31, 2024$846.99M+18.4%
Q4 FY2023Dec 31, 2023$811.45M+20.4%
Q3 FY2023Sep 30, 2023$777.77M+20.9%
Q2 FY2023Jun 30, 2023$760.18M+50.5%
Q1 FY2023Mar 31, 2023$715.09M+54.1%
Q4 FY2022Dec 31, 2022$673.87M+55.5%
Q3 FY2022Sep 30, 2022$643.46M+64.5%
Q2 FY2022Jun 30, 2022$505.03M+40.4%
Q1 FY2022Mar 31, 2022$464.01M+37.6%
Q4 FY2021Dec 31, 2021$433.44M+1.5%
Q3 FY2021Sep 30, 2021$391.09M+22.2%
Q2 FY2021Jun 30, 2021$359.70M+237.1%
Q1 FY2021Mar 31, 2021$337.25M–
Q4 FY2020Dec 31, 2020$427.07M–
Q3 FY2020Sep 30, 2020$320.07M–
Q4 FY2019Dec 31, 2019$106.70M–

More Harmony Biosciences figures

See a number that looks wrong?